カテゴリー： LP Information, 世界, 医療/バイオ

世界のがん幹細胞（CSC）市場予測 2021年-2026年

【英語タイトル】Global Cancer Stem Cells (CSCs) Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9460）・商品コード：LPI21MY9460
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：181
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「がん幹細胞（CSC）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、セルサーチ、その他など、用途別には、乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他がん診断・治療などにセグメント区分してまとめました。がん幹細胞（CSC）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・がん幹細胞（CSC）の世界市場概要（サマリー）
・がん幹細胞（CSC）の企業別販売量・売上
・がん幹細胞（CSC）の企業別市場シェア
・がん幹細胞（CSC）の世界市場規模 2016年-2021年：種類別（セルサーチ、その他）
・がん幹細胞（CSC）の世界市場規模 2016年-2021年：用途別（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他がん診断・治療）
・がん幹細胞（CSC）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・がん幹細胞（CSC）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・がん幹細胞（CSC）のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・がん幹細胞（CSC）の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・がん幹細胞（CSC）市場の成長要因・課題・動向
・がん幹細胞（CSC）の世界市場予測 2021年-2026年
・がん幹細胞（CSC）の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・がん幹細胞（CSC）のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・がん幹細胞（CSC）のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・がん幹細胞（CSC）の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・がん幹細胞（CSC）の世界市場予測：種類別（セルサーチ、その他）
・がん幹細胞（CSC）の世界市場予測：用途別（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他がん診断・治療）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Cancer Stem Cells (CSCs) will have significant change from previous year. By the most conservative estimates of global Cancer Stem Cells (CSCs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cancer Stem Cells (CSCs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Stem Cells (CSCs) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
CellSearch
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Creatv MicroTech
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
Aviva Biosciences Corporation
ScreenCell
Silicon Biosystems

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Stem Cells (CSCs) Consumption 2016-2026
2.1.2 Cancer Stem Cells (CSCs) Consumption CAGR by Region
2.2 Cancer Stem Cells (CSCs) Segment by Type
2.2.1 CellSearch
2.2.2 Others
2.3 Cancer Stem Cells (CSCs) Sales by Type
2.3.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
2.3.2 Global Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Cancer Stem Cells (CSCs) Sale Price by Type (2016-2021)
2.4 Cancer Stem Cells (CSCs) Segment by Application
2.4.1 Breast Cancer Diagnosis and Treatment
2.4.2 Prostate Cancer Diagnosis and Treatment
2.4.3 Colorectal Cancer Diagnosis and Treatment
2.4.4 Lung Cancer Diagnosis and Treatment
2.4.5 Other Cancers Diagnosis and Treatment
2.5 Cancer Stem Cells (CSCs) Sales by Application
2.5.1 Global Cancer Stem Cells (CSCs) Sale Market Share by Application (2016-2021)
2.5.2 Global Cancer Stem Cells (CSCs) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Cancer Stem Cells (CSCs) Sale Price by Application (2016-2021)

3 Global Cancer Stem Cells (CSCs) by Company
3.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Company
3.1.1 Global Cancer Stem Cells (CSCs) Sales by Company (2019-2021)
3.1.2 Global Cancer Stem Cells (CSCs) Sales Market Share by Company (2019-2021)
3.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Company
3.2.1 Global Cancer Stem Cells (CSCs) Revenue by Company (2019-2021)
3.2.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Company (2019-2021)
3.3 Global Cancer Stem Cells (CSCs) Sale Price by Company
3.4 Global Manufacturers Cancer Stem Cells (CSCs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cancer Stem Cells (CSCs) Product Location Distribution
3.4.2 Players Cancer Stem Cells (CSCs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cancer Stem Cells (CSCs) by Region
4.1 Global Cancer Stem Cells (CSCs) by Region
4.1.1 Global Cancer Stem Cells (CSCs) Sales by Region
4.1.2 Global Cancer Stem Cells (CSCs) Revenue by Region
4.2 Americas Cancer Stem Cells (CSCs) Sales Growth
4.3 APAC Cancer Stem Cells (CSCs) Sales Growth
4.4 Europe Cancer Stem Cells (CSCs) Sales Growth
4.5 Middle East & Africa Cancer Stem Cells (CSCs) Sales Growth

5 Americas
5.1 Americas Cancer Stem Cells (CSCs) Sales by Country
5.1.1 Americas Cancer Stem Cells (CSCs) Sales by Country (2016-2021)
5.1.2 Americas Cancer Stem Cells (CSCs) Revenue by Country (2016-2021)
5.2 Americas Cancer Stem Cells (CSCs) Sales by Type
5.3 Americas Cancer Stem Cells (CSCs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cancer Stem Cells (CSCs) Sales by Region
6.1.1 APAC Cancer Stem Cells (CSCs) Sales by Region (2016-2021)
6.1.2 APAC Cancer Stem Cells (CSCs) Revenue by Region (2016-2021)
6.2 APAC Cancer Stem Cells (CSCs) Sales by Type
6.3 APAC Cancer Stem Cells (CSCs) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cancer Stem Cells (CSCs) by Country
7.1.1 Europe Cancer Stem Cells (CSCs) Sales by Country (2016-2021)
7.1.2 Europe Cancer Stem Cells (CSCs) Revenue by Country (2016-2021)
7.2 Europe Cancer Stem Cells (CSCs) Sales by Type
7.3 Europe Cancer Stem Cells (CSCs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cancer Stem Cells (CSCs) by Country
8.1.1 Middle East & Africa Cancer Stem Cells (CSCs) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Cancer Stem Cells (CSCs) Revenue by Country (2016-2021)
8.2 Middle East & Africa Cancer Stem Cells (CSCs) Sales by Type
8.3 Middle East & Africa Cancer Stem Cells (CSCs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Stem Cells (CSCs) Distributors
10.3 Cancer Stem Cells (CSCs) Customer

11 Global Cancer Stem Cells (CSCs) Market Forecast
11.1 Global Cancer Stem Cells (CSCs) Forecast by Region
11.1.1 Global Cancer Stem Cells (CSCs) Forecast by Regions (2021-2026)
11.2.2 Global Cancer Stem Cells (CSCs) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Cancer Stem Cells (CSCs) Forecast by Type
11.7 Global Cancer Stem Cells (CSCs) Forecast by Application

12 Key Players Analysis
12.1 Janssen
12.1.1 Janssen Janssen Company Information
12.1.2 Janssen Cancer Stem Cells (CSCs) Product Offered
12.1.3 Janssen Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Janssen Main Business Overview
12.1.5 Janssen Latest Developments
12.2 Qiagen
12.2.1 Qiagen Company Information
12.2.2 Qiagen Cancer Stem Cells (CSCs) Product Offered
12.2.3 Qiagen Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Qiagen Main Business Overview
12.2.5 Qiagen Latest Developments
12.3 Advanced Cell Diagnostics
12.3.1 Advanced Cell Diagnostics Company Information
12.3.2 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Product Offered
12.3.3 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Advanced Cell Diagnostics Main Business Overview
12.3.5 Advanced Cell Diagnostics Latest Developments
12.4 ApoCell
12.4.1 ApoCell Company Information
12.4.2 ApoCell Cancer Stem Cells (CSCs) Product Offered
12.4.3 ApoCell Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 ApoCell Main Business Overview
12.4.5 ApoCell Latest Developments
12.5 Biofluidica
12.5.1 Biofluidica Company Information
12.5.2 Biofluidica Cancer Stem Cells (CSCs) Product Offered
12.5.3 Biofluidica Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Biofluidica Main Business Overview
12.5.5 Biofluidica Latest Developments
12.6 Clearbridge Biomedics
12.6.1 Clearbridge Biomedics Company Information
12.6.2 Clearbridge Biomedics Cancer Stem Cells (CSCs) Product Offered
12.6.3 Clearbridge Biomedics Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Clearbridge Biomedics Main Business Overview
12.6.5 Clearbridge Biomedics Latest Developments
12.7 CytoTrack
12.7.1 CytoTrack Company Information
12.7.2 CytoTrack Cancer Stem Cells (CSCs) Product Offered
12.7.3 CytoTrack Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 CytoTrack Main Business Overview
12.7.5 CytoTrack Latest Developments
12.8 Celsee
12.8.1 Celsee Company Information
12.8.2 Celsee Cancer Stem Cells (CSCs) Product Offered
12.8.3 Celsee Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Celsee Main Business Overview
12.8.5 Celsee Latest Developments
12.9 Fluxion
12.9.1 Fluxion Company Information
12.9.2 Fluxion Cancer Stem Cells (CSCs) Product Offered
12.9.3 Fluxion Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Fluxion Main Business Overview
12.9.5 Fluxion Latest Developments
12.10 Gilupi
12.10.1 Gilupi Company Information
12.10.2 Gilupi Cancer Stem Cells (CSCs) Product Offered
12.10.3 Gilupi Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Gilupi Main Business Overview
12.10.5 Gilupi Latest Developments
12.11 Cynvenio
12.11.1 Cynvenio Company Information
12.11.2 Cynvenio Cancer Stem Cells (CSCs) Product Offered
12.11.3 Cynvenio Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Cynvenio Main Business Overview
12.11.5 Cynvenio Latest Developments
12.12 On-chip
12.12.1 On-chip Company Information
12.12.2 On-chip Cancer Stem Cells (CSCs) Product Offered
12.12.3 On-chip Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 On-chip Main Business Overview
12.12.5 On-chip Latest Developments
12.13 YZY Bio
12.13.1 YZY Bio Company Information
12.13.2 YZY Bio Cancer Stem Cells (CSCs) Product Offered
12.13.3 YZY Bio Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 YZY Bio Main Business Overview
12.13.5 YZY Bio Latest Developments
12.14 BioView
12.14.1 BioView Company Information
12.14.2 BioView Cancer Stem Cells (CSCs) Product Offered
12.14.3 BioView Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 BioView Main Business Overview
12.14.5 BioView Latest Developments
12.15 Creatv MicroTech
12.15.1 Creatv MicroTech Company Information
12.15.2 Creatv MicroTech Cancer Stem Cells (CSCs) Product Offered
12.15.3 Creatv MicroTech Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Creatv MicroTech Main Business Overview
12.15.5 Creatv MicroTech Latest Developments
12.16 Fluidigm
12.16.1 Fluidigm Company Information
12.16.2 Fluidigm Cancer Stem Cells (CSCs) Product Offered
12.16.3 Fluidigm Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Fluidigm Main Business Overview
12.16.5 Fluidigm Latest Developments
12.17 Ikonisys
12.17.1 Ikonisys Company Information
12.17.2 Ikonisys Cancer Stem Cells (CSCs) Product Offered
12.17.3 Ikonisys Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Ikonisys Main Business Overview
12.17.5 Ikonisys Latest Developments
12.18 AdnaGen
12.18.1 AdnaGen Company Information
12.18.2 AdnaGen Cancer Stem Cells (CSCs) Product Offered
12.18.3 AdnaGen Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 AdnaGen Main Business Overview
12.18.5 AdnaGen Latest Developments
12.19 IVDiagnostics
12.19.1 IVDiagnostics Company Information
12.19.2 IVDiagnostics Cancer Stem Cells (CSCs) Product Offered
12.19.3 IVDiagnostics Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 IVDiagnostics Main Business Overview
12.19.5 IVDiagnostics Latest Developments
12.20 Miltenyi Biotec
12.20.1 Miltenyi Biotec Company Information
12.20.2 Miltenyi Biotec Cancer Stem Cells (CSCs) Product Offered
12.20.3 Miltenyi Biotec Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Miltenyi Biotec Main Business Overview
12.20.5 Miltenyi Biotec Latest Developments
12.21 Aviva Biosciences Corporation
12.21.1 Aviva Biosciences Corporation Company Information
12.21.2 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Product Offered
12.21.3 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Aviva Biosciences Corporation Main Business Overview
12.21.5 Aviva Biosciences Corporation Latest Developments
12.22 ScreenCell
12.22.1 ScreenCell Company Information
12.22.2 ScreenCell Cancer Stem Cells (CSCs) Product Offered
12.22.3 ScreenCell Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 ScreenCell Main Business Overview
12.22.5 ScreenCell Latest Developments
12.23 Silicon Biosystems
12.23.1 Silicon Biosystems Company Information
12.23.2 Silicon Biosystems Cancer Stem Cells (CSCs) Product Offered
12.23.3 Silicon Biosystems Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.23.4 Silicon Biosystems Main Business Overview
12.23.5 Silicon Biosystems Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Cancer Stem Cells (CSCs) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of CellSearch
Table 3. Major Players of Others
Table 4. Global Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 5. Global Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 6. Global Cancer Stem Cells (CSCs) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Cancer Stem Cells (CSCs) Revenue Market Share by Type (2016-2021)
Table 8. Global Cancer Stem Cells (CSCs) Sale Price by Type (2016-2021)
Table 9. Global Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 10. Global Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 11. Global Cancer Stem Cells (CSCs) Value by Application (2016-2021)
Table 12. Global Cancer Stem Cells (CSCs) Revenue Market Share by Application (2016-2021)
Table 13. Global Cancer Stem Cells (CSCs) Sale Price by Application (2016-2021)
Table 14. Global Cancer Stem Cells (CSCs) Sales by Company (2019-2021) & (K Units)
Table 15. Global Cancer Stem Cells (CSCs) Sales Market Share by Company (2019-2021)
Table 16. Global Cancer Stem Cells (CSCs) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Cancer Stem Cells (CSCs) Revenue Market Share by Company (2019-2021)
Table 18. Global Cancer Stem Cells (CSCs) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Cancer Stem Cells (CSCs) Producing Area Distribution and Sales Area
Table 20. Players Cancer Stem Cells (CSCs) Products Offered
Table 21. Cancer Stem Cells (CSCs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Cancer Stem Cells (CSCs) Sales by Region (2016-2021) (K Units)
Table 25. Global Cancer Stem Cells (CSCs) Sales Market Share by Region (2016-2021)
Table 26. Global Cancer Stem Cells (CSCs) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Cancer Stem Cells (CSCs) Revenue Market Share by Region (2016-2021)
Table 28. Americas Cancer Stem Cells (CSCs) Sales by Country (2016-2021) & (K Units)
Table 29. Americas Cancer Stem Cells (CSCs) Sales Market Share by Country (2016-2021)
Table 30. Americas Cancer Stem Cells (CSCs) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Cancer Stem Cells (CSCs) Revenue Market Share by Country (2016-2021)
Table 32. Americas Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 33. Americas Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 34. Americas Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 35. Americas Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 36. APAC Cancer Stem Cells (CSCs) Sales by Region (2016-2021) & (K Units)
Table 37. APAC Cancer Stem Cells (CSCs) Sales Market Share by Region (2016-2021)
Table 38. APAC Cancer Stem Cells (CSCs) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Cancer Stem Cells (CSCs) Revenue Market Share by Region (2016-2021)
Table 40. APAC Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 41. APAC Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 42. APAC Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 43. APAC Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 44. Europe Cancer Stem Cells (CSCs) Sales by Country (2016-2021) & (K Units)
Table 45. Europe Cancer Stem Cells (CSCs) Sales Market Share by Country (2016-2021)
Table 46. Europe Cancer Stem Cells (CSCs) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Cancer Stem Cells (CSCs) Revenue Market Share by Country (2016-2021)
Table 48. Europe Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 49. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 50. Europe Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 51. Europe Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Cancer Stem Cells (CSCs) Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Cancer Stem Cells (CSCs) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Cancer Stem Cells (CSCs) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 60. Global Cancer Stem Cells (CSCs) Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Cancer Stem Cells (CSCs) Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Cancer Stem Cells (CSCs) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Cancer Stem Cells (CSCs) Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Cancer Stem Cells (CSCs) Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Cancer Stem Cells (CSCs) Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Cancer Stem Cells (CSCs) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Cancer Stem Cells (CSCs) Revenue Market Share Forecast by Application (2021-2026)
Table 68. Janssen Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 69. Janssen Cancer Stem Cells (CSCs) Product Offered
Table 70. Janssen Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. Janssen Main Business
Table 72. Janssen Latest Developments
Table 73. Qiagen Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 74. Qiagen Cancer Stem Cells (CSCs) Product Offered
Table 75. Qiagen Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Qiagen Main Business
Table 77. Qiagen Latest Developments
Table 78. Advanced Cell Diagnostics Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 79. Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Product Offered
Table 80. Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Advanced Cell Diagnostics Main Business
Table 82. Advanced Cell Diagnostics Latest Developments
Table 83. ApoCell Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 84. ApoCell Cancer Stem Cells (CSCs) Product Offered
Table 85. ApoCell Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. ApoCell Main Business
Table 87. ApoCell Latest Developments
Table 88. Biofluidica Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 89. Biofluidica Cancer Stem Cells (CSCs) Product Offered
Table 90. Biofluidica Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Biofluidica Main Business
Table 92. Biofluidica Latest Developments
Table 93. Clearbridge Biomedics Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 94. Clearbridge Biomedics Cancer Stem Cells (CSCs) Product Offered
Table 95. Clearbridge Biomedics Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Clearbridge Biomedics Main Business
Table 97. Clearbridge Biomedics Latest Developments
Table 98. CytoTrack Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 99. CytoTrack Cancer Stem Cells (CSCs) Product Offered
Table 100. CytoTrack Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. CytoTrack Main Business
Table 102. CytoTrack Latest Developments
Table 103. Celsee Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 104. Celsee Cancer Stem Cells (CSCs) Product Offered
Table 105. Celsee Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Celsee Main Business
Table 107. Celsee Latest Developments
Table 108. Fluxion Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 109. Fluxion Cancer Stem Cells (CSCs) Product Offered
Table 110. Fluxion Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Fluxion Main Business
Table 112. Fluxion Latest Developments
Table 113. Gilupi Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 114. Gilupi Cancer Stem Cells (CSCs) Product Offered
Table 115. Gilupi Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Gilupi Main Business
Table 117. Gilupi Latest Developments
Table 118. Cynvenio Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 119. Cynvenio Cancer Stem Cells (CSCs) Product Offered
Table 120. Cynvenio Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Cynvenio Main Business
Table 122. Cynvenio Latest Developments
Table 123. On-chip Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 124. On-chip Cancer Stem Cells (CSCs) Product Offered
Table 125. On-chip Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. On-chip Main Business
Table 127. On-chip Latest Developments
Table 128. YZY Bio Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 129. YZY Bio Cancer Stem Cells (CSCs) Product Offered
Table 130. YZY Bio Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. YZY Bio Main Business
Table 132. YZY Bio Latest Developments
Table 133. BioView Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 134. BioView Cancer Stem Cells (CSCs) Product Offered
Table 135. BioView Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. BioView Main Business
Table 137. BioView Latest Developments
Table 138. Creatv MicroTech Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 139. Creatv MicroTech Cancer Stem Cells (CSCs) Product Offered
Table 140. Creatv MicroTech Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Creatv MicroTech Main Business
Table 142. Creatv MicroTech Latest Developments
Table 143. Fluidigm Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 144. Fluidigm Cancer Stem Cells (CSCs) Product Offered
Table 145. Fluidigm Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. Fluidigm Main Business
Table 147. Fluidigm Latest Developments
Table 148. Ikonisys Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 149. Ikonisys Cancer Stem Cells (CSCs) Product Offered
Table 150. Ikonisys Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. Ikonisys Main Business
Table 152. Ikonisys Latest Developments
Table 153. AdnaGen Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 154. AdnaGen Cancer Stem Cells (CSCs) Product Offered
Table 155. AdnaGen Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 156. AdnaGen Main Business
Table 157. AdnaGen Latest Developments
Table 158. IVDiagnostics Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 159. IVDiagnostics Cancer Stem Cells (CSCs) Product Offered
Table 160. IVDiagnostics Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 161. IVDiagnostics Main Business
Table 162. IVDiagnostics Latest Developments
Table 163. Miltenyi Biotec Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 164. Miltenyi Biotec Cancer Stem Cells (CSCs) Product Offered
Table 165. Miltenyi Biotec Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 166. Miltenyi Biotec Main Business
Table 167. Miltenyi Biotec Latest Developments
Table 168. Aviva Biosciences Corporation Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 169. Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Product Offered
Table 170. Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 171. Aviva Biosciences Corporation Main Business
Table 172. Aviva Biosciences Corporation Latest Developments
Table 173. ScreenCell Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 174. ScreenCell Cancer Stem Cells (CSCs) Product Offered
Table 175. ScreenCell Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 176. ScreenCell Main Business
Table 177. ScreenCell Latest Developments
Table 178. Silicon Biosystems Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 179. Silicon Biosystems Cancer Stem Cells (CSCs) Product Offered
Table 180. Silicon Biosystems Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 181. Silicon Biosystems Main Business
Table 182. Silicon Biosystems Latest Developments
List of Figures
Figure 1. Picture of Cancer Stem Cells (CSCs)
Figure 2. Cancer Stem Cells (CSCs) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cancer Stem Cells (CSCs) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Cancer Stem Cells (CSCs) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Cancer Stem Cells (CSCs) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of CellSearch
Figure 10. Product Picture of Others
Figure 11. Global Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 12. Global Cancer Stem Cells (CSCs) Revenue Market Share by Type (2016-2021)
Figure 13. Cancer Stem Cells (CSCs) Consumed in Breast Cancer Diagnosis and Treatment
Figure 14. Global Cancer Stem Cells (CSCs) Market: Breast Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 15. Cancer Stem Cells (CSCs) Consumed in Prostate Cancer Diagnosis and Treatment
Figure 16. Global Cancer Stem Cells (CSCs) Market: Prostate Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 17. Cancer Stem Cells (CSCs) Consumed in Colorectal Cancer Diagnosis and Treatment
Figure 18. Global Cancer Stem Cells (CSCs) Market: Colorectal Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 19. Cancer Stem Cells (CSCs) Consumed in Lung Cancer Diagnosis and Treatment
Figure 20. Global Cancer Stem Cells (CSCs) Market: Lung Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 21. Cancer Stem Cells (CSCs) Consumed in Other Cancers Diagnosis and Treatment
Figure 22. Global Cancer Stem Cells (CSCs) Market: Other Cancers Diagnosis and Treatment (2016-2021) & (K Units)
Figure 23. Global Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Figure 24. Global Cancer Stem Cells (CSCs) Revenue Market Share by Application in 2020
Figure 25. Global Cancer Stem Cells (CSCs) Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Cancer Stem Cells (CSCs) Revenue Market Share by Company in 2020
Figure 27. Global Cancer Stem Cells (CSCs) Sales Market Share by Regions (2016-2021)
Figure 28. Global Cancer Stem Cells (CSCs) Revenue Market Share by Region in 2020
Figure 29. Americas Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 30. Americas Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 31. APAC Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 32. APAC Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 33. Europe Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 34. Europe Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 36. Middle East & Africa Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 37. Americas Cancer Stem Cells (CSCs) Sales Market Share by Country in 2020
Figure 38. Americas Cancer Stem Cells (CSCs) Revenue Market Share by Country in 2020
Figure 39. Americas Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 40. Americas Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 41. United States Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Cancer Stem Cells (CSCs) Sales Market Share by Region in 2020
Figure 46. APAC Cancer Stem Cells (CSCs) Revenue Market Share by Regions in 2020
Figure 47. APAC Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 48. APAC Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 49. China Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Cancer Stem Cells (CSCs) Sales Market Share by Country in 2020
Figure 56. Europe Cancer Stem Cells (CSCs) Revenue Market Share by Country in 2020
Figure 57. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 58. Europe Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 59. Germany Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Cancer Stem Cells (CSCs) Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 68. Egypt Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


★調査レポート[世界のがん幹細胞（CSC）市場予測 2021年-2026年] (コード：LPI21MY9460)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん幹細胞（CSC）市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の幹細胞特性評価キット市場予測 2021年-2026年
    LPI21MY9273 / LP Information / 2021年5月 / LPインフォメーション社の「幹細胞特性評価キットの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、胚性幹細胞、間葉系幹細胞、人工多能性幹細胞など、用途別には、バイオ医薬品企業、委託研究機関、学術研究機関、バイオ技術企業などにセグメント区分してまとめました。幹細胞特性評価キットのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・幹細胞特性評価キットの世界市場概要（サマリー） ・幹細胞特性評価キットの企業別販売量・売上 ・幹細胞特性評価キットの企業別市場シェア ・幹細胞特性評価キットの世界市場規模 2016年-2021年：種類別（胚性幹細胞、間葉系幹細胞、人工多能性幹細胞） ・幹細胞特性評価キットの世界市場規模 2016年-2021年：用途別（バイオ医薬品企業、委託研究機関、学術研究機関、バイオ技術企業） ・幹細胞特性評価キットの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・幹細胞特性評価キットのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Stem Cell Characterization Kits will have significant change from previous year. By the most conservative estimates of global Stem Cell Characterization Kits market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Stem Cell Characterization Kits market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Characterization Kits...
  • 人工多能性幹細胞（iPSC）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103577 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、人工多能性幹細胞（iPSC）の世界市場について調べ、まとめました。種類別セグメントは、ヒトiPSC、マウスiPSC等、用途別セグメントは、学術研究、医薬品の開発と発見、毒性スクリーニング、再生医学等に区分しました。人工多能性幹細胞（iPSC）の世界市場概観、企業動向、企業別人工多能性幹細胞（iPSC）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・人工多能性幹細胞（iPSC）の市場概観 ・人工多能性幹細胞（iPSC）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・人工多能性幹細胞（iPSC）の企業別販売動向、市場シェア、市場集中度、競争動向 ・人工多能性幹細胞（iPSC）の世界市場規模 ・人工多能性幹細胞（iPSC）の北米市場分析（アメリカ、カナダ、メキシコ等） ・人工多能性幹細胞（iPSC）のアメリカ市場規模推移 ・人工多能性幹細胞（iPSC）のカナダ市場規模推移 ・人工多能性幹細胞（iPSC）のメキシコ市場規模推移 ・人工多能性幹細胞（iPSC）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Induced Pluripotent Stem Cells (iPSCs) market is valued at 74 million USD in 2018 and is expected to reach 114.9 million USD by the end of 2024, growing at a CAGR of 11.7% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Induced Pluripotent Stem Cells (iPSCs). Europe also...
  • 世界のヒト初代細胞市場予測 2021年-2026年
    LPI21MY9234 / LP Information / 2021年5月 / LPインフォメーション社の「ヒト初代細胞の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、上皮細胞、線維芽細胞、造血細胞、肝細胞、間葉系幹細胞、筋肉細胞、周皮細胞など、用途別には、医療、科学研究、その他などにセグメント区分してまとめました。ヒト初代細胞のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ヒト初代細胞の世界市場概要（サマリー） ・ヒト初代細胞の企業別販売量・売上 ・ヒト初代細胞の企業別市場シェア ・ヒト初代細胞の世界市場規模 2016年-2021年：種類別（上皮細胞、線維芽細胞、造血細胞、肝細胞、間葉系幹細胞、筋肉細胞、周皮細胞） ・ヒト初代細胞の世界市場規模 2016年-2021年：用途別（医療、科学研究、その他） ・ヒト初代細胞の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ヒト初代細胞のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Human Primary Cells will have significant change from previous year. By the most conservative estimates of global Human Primary Cells market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Human Primary Cells market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Human Primary Cells market by product type,...
  • 世界の幹細胞ソース市場予測 2021年-2026年
    LPI21MY9656 / LP Information / 2021年5月 / LPインフォメーション社の「幹細胞ソースの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、試薬、機器、その他など、用途別には、病院、バイオ技術研究センター、その他などにセグメント区分してまとめました。幹細胞ソースのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・幹細胞ソースの世界市場概要（サマリー） ・幹細胞ソースの企業別販売量・売上 ・幹細胞ソースの企業別市場シェア ・幹細胞ソースの世界市場規模 2016年-2021年：種類別（試薬、機器、その他） ・幹細胞ソースの世界市場規模 2016年-2021年：用途別（病院、バイオ技術研究センター、その他） ・幹細胞ソースの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・幹細胞ソースのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Stem Cell Source will have significant change from previous year. By the most conservative estimates of global Stem Cell Source market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Stem Cell Source market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Source market by product type,...
  • 世界の機械的循環サポート（MCS）市場予測 2021年-2026年
    LPI21MY9076 / LP Information / 2021年5月 / LPインフォメーション社の「機械的循環サポート（MCS）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、体外式膜型人工肺装置、体外式補助人工心臓、その他など、用途別には、病院、専門心臓センター、外来手術センター、その他などにセグメント区分してまとめました。機械的循環サポート（MCS）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・機械的循環サポート（MCS）の世界市場概要（サマリー） ・機械的循環サポート（MCS）の企業別販売量・売上 ・機械的循環サポート（MCS）の企業別市場シェア ・機械的循環サポート（MCS）の世界市場規模 2016年-2021年：種類別（体外式膜型人工肺装置、体外式補助人工心臓、その他） ・機械的循環サポート（MCS）の世界市場規模 2016年-2021年：用途別（病院、専門心臓センター、外来手術センター、その他） ・機械的循環サポート（MCS）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・機械的循環サポート（MCS）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Mechanical Circulatory Support (MCS) will have significant change from previous year. By the most conservative estimates of global Mechanical Circulatory Support (MCS) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mechanical Circulatory Support (MCS) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Mechanical Circulatory Support (MCS)...
  • 世界の薬剤溶出性バルーン（DEB）市場予測 2021年-2026年
    LPI21MY9512 / LP Information / 2021年5月 / LPインフォメーション社の「薬剤溶出性バルーン（DEB）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パコキャスバルーン、シークエントプリーズバルーン、In.Pactファルコンバルーン、DIORバルーンなど、用途別には、冠状動脈疾患、末梢動脈疾患、肥満・糖尿病、その他などにセグメント区分してまとめました。薬剤溶出性バルーン（DEB）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・薬剤溶出性バルーン（DEB）の世界市場概要（サマリー） ・薬剤溶出性バルーン（DEB）の企業別販売量・売上 ・薬剤溶出性バルーン（DEB）の企業別市場シェア ・薬剤溶出性バルーン（DEB）の世界市場規模 2016年-2021年：種類別（パコキャスバルーン、シークエントプリーズバルーン、In.Pactファルコンバルーン、DIORバルーン） ・薬剤溶出性バルーン（DEB）の世界市場規模 2016年-2021年：用途別（冠状動脈疾患、末梢動脈疾患、肥満・糖尿病、その他） ・薬剤溶出性バルーン（DEB）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・薬剤溶出性バルーン（DEB）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Drug Eluting Balloons（DEB） will have significant change from previous year. By the most conservative estimates of global Drug Eluting Balloons（DEB） market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Drug Eluting Balloons（DEB） market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloons（DEB） market by product type,...
  • 世界の自動体外式除細動器（AED）市場予測 2021年-2026年
    LPI21MY8739 / LP Information / 2021年5月 / LPインフォメーション社の「自動体外式除細動器（AED）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、全自動型、半自動型など、用途別には、病院、公的アクセス、家庭、トレーニング、その他などにセグメント区分してまとめました。自動体外式除細動器（AED）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・自動体外式除細動器（AED）の世界市場概要（サマリー） ・自動体外式除細動器（AED）の企業別販売量・売上 ・自動体外式除細動器（AED）の企業別市場シェア ・自動体外式除細動器（AED）の世界市場規模 2016年-2021年：種類別（全自動型、半自動型） ・自動体外式除細動器（AED）の世界市場規模 2016年-2021年：用途別（病院、公的アクセス、家庭、トレーニング、その他） ・自動体外式除細動器（AED）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・自動体外式除細動器（AED）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Automated External Defibrillator will have significant change from previous year. By the most conservative estimates of global Automated External Defibrillator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 750.5 million in 2019. Over the next five years the Automated External Defibrillator market will register a 4.4% CAGR in terms of revenue, the global market size will reach US$ 890.1 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Automated External Defibrillator market by product type,...
  • 世界のアルブミン（ヒト）市場予測 2021年-2026年
    LPI21MY9393 / LP Information / 2021年5月 / LPインフォメーション社の「アルブミン（ヒト）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射、凍結乾燥注射など、用途別には、肝臓病、腎臓病、新生物、その他病気などにセグメント区分してまとめました。アルブミン（ヒト）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アルブミン（ヒト）の世界市場概要（サマリー） ・アルブミン（ヒト）の企業別販売量・売上 ・アルブミン（ヒト）の企業別市場シェア ・アルブミン（ヒト）の世界市場規模 2016年-2021年：種類別（注射、凍結乾燥注射） ・アルブミン（ヒト）の世界市場規模 2016年-2021年：用途別（肝臓病、腎臓病、新生物、その他病気） ・アルブミン（ヒト）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アルブミン（ヒト）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Albumin (Human) will have significant change from previous year. By the most conservative estimates of global Albumin (Human) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Albumin (Human) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (Human) market by product type, application, key manufacturers and...
  • 世界のコンピュータ断層撮影（CT）市場予測 2021年-2026年
    LPI21MY8850 / LP Information / 2021年5月 / LPインフォメーション社の「コンピュータ断層撮影（CT）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、心臓血管、腫瘍、神経血管、腹部・骨盤、肺血管造影、脊椎、筋骨格など、用途別には、診断センター、病院、その他などにセグメント区分してまとめました。コンピュータ断層撮影（CT）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・コンピュータ断層撮影（CT）の世界市場概要（サマリー） ・コンピュータ断層撮影（CT）の企業別販売量・売上 ・コンピュータ断層撮影（CT）の企業別市場シェア ・コンピュータ断層撮影（CT）の世界市場規模 2016年-2021年：種類別（心臓血管、腫瘍、神経血管、腹部・骨盤、肺血管造影、脊椎、筋骨格） ・コンピュータ断層撮影（CT）の世界市場規模 2016年-2021年：用途別（診断センター、病院、その他） ・コンピュータ断層撮影（CT）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・コンピュータ断層撮影（CT）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Computed Tomography (CT) will have significant change from previous year. By the most conservative estimates of global Computed Tomography (CT) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4288.8 million in 2019. Over the next five years the Computed Tomography (CT) market will register a 3.5% CAGR in terms of revenue, the global market size will reach US$ 4915.8 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Computed Tomography (CT) market by product type,...
  • 世界の標識ペプチド 市場予測 2021年-2026年
    LPI21MY9262 / LP Information / 2021年5月 / LPインフォメーション社の「標識ペプチド の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、（Arg）9、FAMラベル、（Arg）9、TAMRAラベル、その他など、用途別には、タンパク質化学、免疫学、組織化学、その他などにセグメント区分してまとめました。標識ペプチド のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・標識ペプチド の世界市場概要（サマリー） ・標識ペプチド の企業別販売量・売上 ・標識ペプチド の企業別市場シェア ・標識ペプチド...According to this latest study, the 2021 growth of Labeled Peptides will have significant change from previous year. By the most conservative estimates of global Labeled Peptides market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Labeled Peptides market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Labeled Peptides market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆